| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $342.6M | +0.9% |
| Cost of Revenue | $168.5M | -4.2% |
| R&D Expense | $34.5M | -7.5% |
| SG&A Expense | $77.0M | +1.1% |
| Operating Income | $6.6M | +115.6% |
| Pre-tax Income | -$10.2M | +81.2% |
| Income Tax | $10.2M | +219.1% |
| Net Income | -$20.4M | +55.4% |
| EPS (Basic) | -$1.38 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.3M | +220.3% |
| Accounts Receivable | $53.8M | -10.0% |
| Inventory | $767K | +61.5% |
| Current Assets | $90.3M | -19.0% |
| Total Assets | $394.4M | -9.2% |
| Current Liabilities | $53.0M | +9.8% |
| Long-term Debt | $171.6M | -13.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $32.1M | +2934.5% |
| Capital Expenditures | $1.6M | +374.9% |
| Investing Cash Flow | $4.1M | +106.9% |
| Financing Cash Flow | -$27.7M | -149.6% |
| Free Cash Flow | $30.5M | +4176.6% |
| +56.2% |
| EPS (Diluted) | -$1.38 | +56.2% |
| Total Liabilities |
| $225.7M |
| -8.9% |
| Stockholders' Equity | $168.7M | -9.6% |